While this review focuses on the resistance mechanisms of EZH2 and PRMT5 in NSCLC, it is critical to acknowledge that HMTs constitute a large family with diverse members whose roles in therapeutic resistance remain underexplored. Here, EZH2 is linked to non-small cell lung carcinoma.